These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 475547

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Serum sialic acid, fucose, sialic acid/fucose ratio as tumor markers in oral cancer.
    Ghosh M, Nayak BR.
    Ann Dent; 1991; 50(2):33-5, 48. PubMed ID: 1785913
    [Abstract] [Full Text] [Related]

  • 5. The diagnostic value of protein bound serum fucose in cancer of the breast.
    Hadjivassiliou A, Castanaki A, Hristou G, Lissaios B.
    Surg Gynecol Obstet; 1975 Feb; 140(2):239-40. PubMed ID: 1124474
    [Abstract] [Full Text] [Related]

  • 6. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
    Molina R, Farrus B, Filella X, Jo J, Zanón G, Pahisa J, Latre M, Muñoz M, Ballesta AM.
    Anticancer Res; 1999 Feb; 19(4A):2557-62. PubMed ID: 10470194
    [Abstract] [Full Text] [Related]

  • 7. Biochemical markers in ovarian cancer.
    Kiricuta I, Bojan O, Munteanu S.
    Arch Geschwulstforsch; 1986 Feb; 56(1):35-8. PubMed ID: 3964031
    [Abstract] [Full Text] [Related]

  • 8. Breast cancer and family history: levels of lipid-associated sialic acid in plasma and absent family history of breast cancer in women who have breast tumors.
    Brower ST, Tartter P, Weiss S, Luderer AA, Lehrer S.
    Mt Sinai J Med; 1995 Nov; 62(6):419-21. PubMed ID: 8692154
    [Abstract] [Full Text] [Related]

  • 9. TPS and CA 15.3 serum values as a guide for treating and monitoring breast cancer patients.
    Giai M, Roagna R, Ponzone R, Biglia N, Sgro L, Perona M, Sismondi P.
    Anticancer Res; 1996 Nov; 16(2):875-81. PubMed ID: 8687144
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Study of serum fucose and serum sialic acid levels in oral squamous cell carcinomia.
    Shashikanth MC, Rao BB.
    Indian J Dent Res; 1994 Nov; 5(4):119-24. PubMed ID: 9495093
    [Abstract] [Full Text] [Related]

  • 12. A case control study of glycoprotein status in ovarian carcinoma.
    Aranganathan S, Senthil K, Nalini N.
    Clin Biochem; 2005 Jun; 38(6):535-9. PubMed ID: 15885233
    [Abstract] [Full Text] [Related]

  • 13. Plasma sialic acid alterations in neoplastic diseases.
    Dwivedi C, Dixit M, Kumar SS, Reddy H, Semenya KA, Hardy RE.
    J Med; 1987 Jun; 18(5-6):323-32. PubMed ID: 3505259
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical application of serum levels of sialic acid, fucose and seromucoid fraction as tumour markers in human leukemias.
    Patel PS, Adhvaryu SG, Balar DB, Parikh BJ, Shah PM.
    Anticancer Res; 1994 Jun; 14(2B):747-51. PubMed ID: 8010734
    [Abstract] [Full Text] [Related]

  • 18. [Behavior of serum sialic acid levels at various stages of neoplastic disease].
    Adamo V, Altavilla G, Caristi N, Chillemi S, Giacobello T, Scalisi R, Palmara D.
    Minerva Med; 1985 Nov 10; 76(43):2067-70. PubMed ID: 4069416
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.